JérémieNoel

Collaborateur

Paris + 33.1.56.59.38.94

Contact

Partager

Jérémie Noel intervient dans les domaines du private equity, des fusions-acquisitions et du droit boursier.

Il assiste régulièrement des cibles, telles qu'Ivalua, Kalray, Less, Lifen, MirSense et Shippeo, et des investisseurs, tels qu'Alven Capital Partners, Andera Partners, Elaia Partners, Hi Inov, Idinvest Partners et Wellington Partners, dans le cadre d'opérations de capital-risque.

Jérémie Noel conseille des entreprises à fort potentiel de croissance, cotées ou non, sur des questions de droit des sociétés et lors de négociations commerciales.

Parmi les transactions représentatives de son expérience figurent les augmentations de capital d'Ivalua, Lendix, Less, MirSense et TRiCares, l'acquisition d'Availpro par AccorHotels et l'introduction en bourse de Kalray.

Expérience

  • Chalfen Ventures leads $18 million Series A financing of Polar AnalyticsJones Day advised Chalfen Ventures as lead investor in the $18 million Series A financing of Polar Analytics, a French startup that develops software empowering consumer brands.
  • Electric Motion receives investment from YamahaJones Day advised Electric Motion SAS, a French company engaged in the design, manufacturing and marketing of electronic motorcycles, in connection with the investment by Yamaha Motor Co., Ltd.
  • Serena Capital participates in €2.66 million pre-seed financing of EdgeeJones Day advised Serena Capital in connection with the €2.66 million pre-seed financing of Edgee, a French company engaged in software development for edge computers.
  • Hedosophia leads €50 million Series A financing of NEATJones Day advised Hedosophia in connection with the €50 million Series A financing of NEAT, a French start-up operating as an embedded insurance broker.
  • Amolyt Pharma acquired by AstraZenecaJones Day advised Amolyt Pharma, a global, clinical-stage biopharmaceutical company specializing in developing therapeutic peptides for rare endocrine and related diseases, in its $1.05 billion acquisition by AstraZeneca.
  • Partech Partners leads €37 million Series B financing of CintooJones Day represented Partech Partners as lead investor in the €37 million Series B financing of Cintoo, the leading provider of cloud-based Reality Data management and collaboration solutions.
  • Skycatcher leads €10 million financing of SekaiJones Day advised Skycatcher in leading the €10 million financing of Sekai, a French start-up specializing in the development of mobile applications for better anime experiences.
  • Silver Lake Waterman, Eurazeo, Partech Partners, Eight Roads, F-Prime, and Serena Capital participate in $54 million Series C financing of OdasevaJones Day advised Silver Lake Waterman, the lead new investor, and Eurazeo, a new investor, as well as historical investors Partech Partners, Eight Roads, F-Prime and Serena Capital in connection with the $54 million Series C financing of Odaseva, the leading enterprise data security platform for Salesforce, along with new investor Crescent Cove.
  • Singular Capital Partners and Cathay Innovation participate in $25 million financing of ResilienceJones Day advised Singular Capital Partners and Cathay Innovation in the $25 million financing of Resilience, a remote patient care solution in oncology.
  • henQ participates in €25 million Series A financing of imaginoJones Day advised henQ in connection with the €25 million Series A financing of imagino, a revenue-first customer experience platform providing brands with clear and actionable insights through its Customer Data Platform (CDP) to enhance their marketing campaigns.
  • Illuminate Financial participates in $16 million Series A financing of GladiaJones Day advised Illuminate Financial in connection with its participation in the $16 million Series A financing of Gladia, a French AI software provider dedicated to artificial intelligence.
  • Elaia Partners and Illuminate Financial lead $4 million financing of Composable PromptsJones Day advised Elaia Partners and Illuminate Financial as lead investors in the $4 million seed financing of Composable Prompts to spearhead enterprise adoption of large language models, through advanced governance, fine-grained security, and virtualization.
  • Bene Bono raises €10 million in financing roundJones Day advised Bene Bono, a French company engaged in the business of consumer food delivery service with an anti-waste approach, in the €10 million financing round led by AXA Ventures Partners with participation of 2050 and historical investors Stride VC and Project A.
  • Geev raises €4.5 millionJones Day advised Geev, a French startup that develops an artificial intelligence collaborative platform dedicated to the donation of objects in connection with its €4.5 million financing.
  • Collective receives investment from Blossom CapitalJones Day advised Collective.work, a French-based company engaged in the development of a software solution for freelancers, in connection with its €7 million round of financing led by Blossom Capital.
  • Lifen raises $58 million in Series C financing roundJones Day represented Lifen, a French-based company that develops and operates a global communication platform to facilitate collaboration among physicians, in connection with a $58 million Series C round of financing led by Creadev and Lauxera Capital Partners.
  • Swile raises $200 million in Series D financingJones Day advised Swile, a French-based tech company that offers digital solutions for employee rewards and benefits through a custom card and app, in connection with its $200 million Series D round of financing led by SoftBank, alongside existing investors Index Ventures, Eurazeo and Bpifrance Large Venture.
  • Amolyt Pharma raises $80 million in Series B financing roundJones Day advised Amolyt Pharma, a French based company engaged in the research and development of new therapeutic strategies for the treatment of rare endocrine and metabolic diseases, in connection with its $80 million Series B round of financing co-led by Sectoral Asset Management and Andera Partners.
  • Revaia leads €22 million Series A financing round of HubloJones Day represented Revaia as lead investor in connection with the €22 million Series A round of financing of Hublo, a French company engaged in the development and operation of services for the management of staff replacements and recruitments for health and medico-social institutions, with participation by Acton Capital.
  • Stride.VC participates as lead investor in €1.5 million financing round of Hors NormesJones Day represented Stride.VC LLP as lead investor in the seed round of financing of Taste It d/b/a Hors Normes, a consumer food delivery service which fights against the waste of fruits and vegetables directly from producers at a lower price.
    •

    Avant d’envoyer cet e-mail, veuillez prendre note de ce qui suit :

    Les informations contenues sur le site www.jonesday.com sont destinées à un usage général et ne constituent pas des conseils juridiques. L’envoi et la réception de cet e-mail n’ont pas pour effet de créer une relation avocat-client. Aucun envoi de votre part à un membre du Cabinet ne sera traité comme confidentiel ou protégé à moins que nous n’ayons donné notre accord pour vous représenter. En envoyant cet e-mail, vous confirmez avoir lu et compris la présente notification.